Acute respiratory manifestations of the abacavir hypersensitivity reaction [1]

AIDS

Volumn 20, Issue 2, 2006, Pages 301-302

  Herring, Sharon J ^a   Krieger, Ana C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CARBOXYLIC ACID DERIVATIVE; DRUG METABOLITE; LAMIVUDINE PLUS ZIDOVUDINE; ZIDOVUDINE;

ADULT; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RESPIRATORY HYPERSENSITIVITY; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 33646021628     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000199833.87606.95     Document Type: Letter

References (4)

1. Hewitt RG. Abacavir hypersensitivity reaction. Clin Infect Dis 2002; 34:1137-1142.
2. El Sahly HM. Development of abacavir hypersensitivity reaction after rechallenge in a previously asymptomatic patient. AIDS 2004; 18:359-360.
3. Aquilina C, Mularczyk M, Lucas F, Viraben R. Unusual clinical presentation of hypersensitivity reaction to abacavir. AIDS 2003; 17:2403-2404.
4. Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci U S A 2004; 101:4180-4185.